1. Home
  2. Investing
  3. Quotes
  4. Stocks
  5. United States
  6. PFE
  7. Overview
    |
    PFE U.S.: NYSE

    江湖电竞登录在线网站

    Watch list Create PFE Alert
    PFE US
    After Hours
    Last Updated: Sep 9, 2022 7:59 p.m. EDT Delayed quote

    $ 47.96

    0.12 0.25%
    After Hours Volume: 1.57M
    Close Chg Chg %
    $47.84 0.76 1.61%
    Advanced Charting
    Volume: 17.51M 65 Day Avg: 18.7M
    94% vs Avg
    47.10 Day Range 47.99
    40.94 52 Week Range 61.71

    Your Watchlists

    Customize 江湖电竞最新版比赛(江湖电竞投注app网站)

    Have Watchlists? Log in to see them here or sign up to get started.

    Create Account … or Log In
    Symbol
    Company
    Price
    Chg/Chg %
    ( Go to Your Watchlist )
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Add Tickers
    No Saved Watchlists

    Create a list of the investments you want to track.

    Create Watchlist …or learn more
    Uh oh

    Something went wrong while loading Watchlist.

    Go to Watchlist

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    Overview

  • Overview
  • Profile
  • Charts
  • Financials
  • Historical Quotes
  • Analyst Estimates
  • Options

    • PFE Overview

    Key Data

    • Open $47.20
    • Day Range 47.10 - 47.99
    • 52 Week Range 40.94 - 61.71
    • Market Cap $264.23B
    • Shares Outstanding 5.61B
    • Public Float 5.61B
    • Beta 0.61
    • Rev. per Employee $1.283M
    • P/E Ratio 9.37
    • EPS $5.11
    • Yield 3.34%
    • Dividend $0.40
    • Ex-Dividend Date Jul 28, 2022
    • Short Interest 67.94M 08/15/22
    • % of Float Shorted 1.21%
    • Average Volume 18.7M

    Performance

    5 Day
    • 4.68%
    1 Month
    • -4.53%
    3 Month
    • -4.26%
    YTD
    • -18.98%
    1 Year
    • 4.94%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 22 Full Ratings

    Recent News

    Read full story

    Pfizer Inc. stock rises Friday, outperforms market

    Sep. 9, 2022 at 5:14 p.m. ET by 江湖电竞最新版比赛(江湖电竞投注app网站) Automation

    Pfizer Gets U.S., Europe Review of Proposed Alopecia Drug

    Sep. 9, 2022 at 6:54 a.m. ET
    Read full story

    Pfizer Inc. stock outperforms competitors on strong trading day

    Sep. 8, 2022 at 5:14 p.m. ET by 江湖电竞最新版比赛(江湖电竞投注app网站) Automation
    Read full story

    Pfizer Inc. stock rises Wednesday, still underperforms market

    Sep. 7, 2022 at 5:14 p.m. ET by 江湖电竞最新版比赛(江湖电竞投注app网站) Automation
    Read full story

    Biotech and Pharma Pfizer Gets FDA ‘Breakthrough’ Designation for Group B Strep Vaccine

    Sep. 7, 2022 at 12:03 p.m. ET by Barron's

    Pfizer Gets FDA Breakthrough Designation for Maternal Use of Group B Streptococcus Vaccine Candidate >PFE

    Sep. 7, 2022 at 7:15 a.m. ET
    Read full story

    Pfizer Inc. stock underperforms Tuesday when compared to competitors despite daily gains

    Sep. 6, 2022 at 5:14 p.m. ET by 江湖电竞最新版比赛(江湖电竞投注app网站) Automation

    Homology Medicines Appoints Albert Seymour as Chief Executive

    Sep. 6, 2022 at 4:13 p.m. ET
    Read full story

    Coronavirus Fall Boosters Are Here. Your Questions, Answered.

    Sep. 6, 2022 at 3:50 p.m. ET by Barron's
    Read full story

    U.K. to begin rollout of new COVID vaccination campaign

    Sep. 3, 2022 at 12:45 p.m. ET by Associated Press
    Read full story

    COVID boosters targeting omicron subvariants expected within days after CDC signs off

    Sep. 3, 2022 at 12:17 a.m. ET by Ciara Linnane
    Read full story

    CDC backs updated COVID-19 boosters to fight omicron; shots expected within days

    Sep. 1, 2022 at 7:43 p.m. ET by Associated Press

    Novavax Covid-19 Vaccine Gets Booster Recommendation From European Regulatory Committee

    Sep. 1, 2022 at 1:59 p.m. ET
    Read full story

    Has it been two months since your last COVID-19 shot? You may soon qualify for a newly designed booster

    Sep. 1, 2022 at 11:10 a.m. ET by Jaimy Lee

    Pfizer, BioNTech Covid-19 Omicron Vaccine Candidate Gets CHMP Approval

    Sep. 1, 2022 at 10:10 a.m. ET

    EU Recommends Updated Covid-19 Booster Shots From Pfizer-BioNTech, Moderna

    Sep. 1, 2022 at 9:14 a.m. ET
    Read full story

    Markets Nvidia Ensnared in Geopolitical Spy Games With China Export Ban

    Sep. 1, 2022 at 7:44 a.m. ET
    Read full story

    New Covid cases, deaths keep falling nearly everywhere, WHO says

    Aug. 31, 2022 at 1:41 p.m. ET by Associated Press
    Read full story

    Coronavirus Moderna and Pfizer Omicron Booster Shots Cleared by FDA

    Aug. 31, 2022 at 11:50 a.m. ET by Barron's
    Read full story

    U.S. clears updated COVID boosters targeting newest variants

    Aug. 31, 2022 at 10:10 a.m. ET by Associated Press

    Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary

    Sep. 9, 2022 at 5:47 p.m. ET on Benzinga.com

    Check Out What Whales Are Doing With PFE

    Sep. 9, 2022 at 4:41 p.m. ET on Benzinga.com

    This Troubling News Could Put a Dent in Pfizer's Sales

    Sep. 9, 2022 at 10:00 a.m. ET on Motley Fool

    Junshi Biosciences Hits Revenue Roadblock Amid Covid Drug Delay

    Sep. 9, 2022 at 9:58 a.m. ET on Benzinga.com

    U.S. FDA And European Medicines Agency Accepted Pfizer's Hair Loss Candidate Submission For Review

    Sep. 9, 2022 at 9:06 a.m. ET on Benzinga.com

    Here's Why These Top 3 COVID-19 Vaccine Stocks Broke Down in August

    Sep. 8, 2022 at 1:00 p.m. ET on Motley Fool

    Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary

    Sep. 7, 2022 at 5:45 p.m. ET on Benzinga.com

    10 Health Care Stocks With Whale Alerts In Today's Session

    Sep. 7, 2022 at 1:58 p.m. ET on Benzinga.com

    Pfizer Whale Trades For September 07

    Sep. 7, 2022 at 1:53 p.m. ET on Benzinga.com

    Pfizer Gets FDA Breakthrough Therapy Designation For GBS Vaccine Candidate

    Sep. 7, 2022 at 8:17 a.m. ET on Benzinga.com

    Why Novavax Stock Sank to a New 52-Week Low Today

    Sep. 6, 2022 at 12:35 p.m. ET on Motley Fool

    Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report

    Sep. 6, 2022 at 12:09 p.m. ET on Benzinga.com

    2 Top Trends to Invest $2,000 in Ahead of the Crowd

    Sep. 5, 2022 at 10:45 a.m. ET on Motley Fool

    White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox

    Sep. 2, 2022 at 1:50 p.m. ET on Benzinga.com

    Moderna Has One Over Pfizer/BioNTech – but It’s Nothing to Do With Patent Infringement

    BioNTech’s offering violates….

    Sep. 2, 2022 at 1:42 p.m. ET on TipRanks.com

    6 No-Brainer Forever Stocks to Buy if You Have Money to Invest

    Sep. 2, 2022 at 12:36 p.m. ET on InvestorPlace.com

    Is Cannabis Legalization The End For Pharma Stocks? New Study Predicts Billions In Losses

    Sep. 2, 2022 at 11:49 a.m. ET on Benzinga.com

    Is Veeva Systems Stock a Buy Now?

    Sep. 2, 2022 at 11:15 a.m. ET on Motley Fool

    3 Stocks to Buy That Won’t Give You Any Headaches

    Sep. 2, 2022 at 11:12 a.m. ET on StockNews.com

    Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

    Sep. 1, 2022 at 6:36 p.m. ET on Benzinga.com

    Pfizer Inc.

    Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.19% $434.84B
    Eli Lilly & Co. 0.70% $299.78B
    Abbott Laboratories 1.39% $187.36B
    Merck & Co. Inc. -0.09% $221.46B
    Novartis AG 0.74% CHF172.8B
    AstraZeneca PLC ADR 0.00% $187.14B
    AstraZeneca PLC -0.11% £162.88B
    Bristol Myers Squibb Co. 1.12% $148.14B
    Amgen Inc. 0.91% $131.3B
    Moderna Inc. 0.71% $55.27B